NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free INNV Stock Alerts $3.91 +0.11 (+2.89%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$3.84▼$4.1050-Day Range$3.80▼$5.1752-Week Range$3.80▼$8.05Volume8,567 shsAverage Volume23,521 shsMarket Capitalization$531.37 millionP/E RatioN/ADividend YieldN/APrice Target$6.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get InnovAge alerts: Email Address InnovAge MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside66.2% Upside$6.50 Price TargetShort InterestBearish1.63% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.01Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.14) to $0.01 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.84 out of 5 starsMedical Sector812th out of 908 stocksHealth Services Industry9th out of 10 stocks 3.0 Analyst's Opinion Consensus RatingInnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageInnovAge has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.63% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 15.2, which indicates bearish sentiment.Change versus previous monthShort interest in InnovAge has recently decreased by 0.22%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INNV. Previous Next 1.7 News and Social Media Coverage News SentimentInnovAge has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for InnovAge this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for INNV on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.41% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.26% of the stock of InnovAge is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.14) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -15.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -15.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About InnovAge Stock (NASDAQ:INNV)InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More INNV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INNV Stock News HeadlinesApril 25, 2024 | americanbankingnews.comContrasting Accelera Innovations (OTCMKTS:ACNV) & InnovAge (NASDAQ:INNV)April 24, 2024 | seekingalpha.comINNV InnovAge Holding Corp.April 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 24, 2024 | globenewswire.comInnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality CareApril 23, 2024 | globenewswire.comInnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024April 5, 2024 | investorplace.com3 Healthcare Stocks Short Sellers Are Prescribing for TroubleMarch 4, 2024 | globenewswire.comInnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote IndependenceFebruary 9, 2024 | au.lifestyle.yahoo.comBootstrapped for 8 years, Xensam has now snapped up $40M for AI that manages software assetsApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.February 9, 2024 | au.lifestyle.yahoo.comIndian parliamentary panel red-flags PhonePe and Google Pay cornering 83% of India's UPI paymentsFebruary 8, 2024 | msn.comTake-Two CEO: ‘GTA 6’ Still Set for 2025, ‘Significant’ Cost Cuts Coming After Weak Outlook but No Current Layoff PlansFebruary 8, 2024 | msn.comArm becomes Britain's sixth most valuable company after shares rise 50%February 8, 2024 | markets.businessinsider.comInnovAge Holding: A Cautious Hold Amidst Mixed Financial SignalsFebruary 7, 2024 | msn.comUS officials believe Chinese hackers lurk in critical infrastructureFebruary 6, 2024 | benzinga.comRecap: InnovAge Holding Q2 EarningsFebruary 6, 2024 | msn.comInnovAge Holding Corp. (INNV) Reports Q2 Loss, Tops Revenue EstimatesFebruary 6, 2024 | finance.yahoo.comInnovAge Holding Corp (INNV) Reports Fiscal Q2 2024 Earnings: Key Financial Metrics RevealedJanuary 12, 2024 | morningstar.comInnovAge Holding Corp INNVDecember 14, 2023 | seekingalpha.comInnovAge Revenue Ticks Up, But Challenges RemainNovember 12, 2023 | finance.yahoo.comInnovAge Holding Corp. (NASDAQ:INNV) Q1 2024 Earnings Call TranscriptNovember 7, 2023 | finance.yahoo.comInnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue EstimatesOctober 24, 2023 | finance.yahoo.comInnovAge to Announce Fiscal First Quarter 2024 Financial Results and Host Conference Call Tuesday, November 7, 2023October 2, 2023 | finance.yahoo.comInnovAge Names Darlene Flaig as New Chief Nursing OfficerSeptember 19, 2023 | seekingalpha.comInnovAge Holding Corp.: Enrollment Growth Metrics Suggest Business Is Recovering WellSeptember 13, 2023 | markets.businessinsider.comInnovAge Holding (INNV) Gets a Hold from CitiSeptember 12, 2023 | marketwatch.comInnovAge Holding Shares Slide 6.9% After Wider-Than-Expected LossSeptember 12, 2023 | finance.yahoo.comInnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue EstimatesSee More Headlines Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/05/2024Today4/26/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:INNV CUSIPN/A CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,100Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$7.00 Low Stock Price Target$6.00 Potential Upside/Downside+66.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-40,670,000.00 Net Margins-4.38% Pretax Margin-4.80% Return on Equity-10.53% Return on Assets-5.69% Debt Debt-to-Equity Ratio0.26 Current Ratio1.27 Quick Ratio1.27 Sales & Book Value Annual Sales$688.09 million Price / Sales0.77 Cash FlowN/A Price / Cash FlowN/A Book Value$2.23 per share Price / Book1.75Miscellaneous Outstanding Shares135,900,000Free Float135,342,000Market Cap$531.37 million OptionableOptionable Beta0.15 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Patrick Blair (Age 53)President & CEO Comp: $1.51MMs. Nicole D'Amato (Age 45)Chief Legal Officer & Corporate Secretary Comp: $678.76kDr. Richard A. Feifer FACP (Age 57)M.D., M.P.H., Chief Medical Officer Comp: $588.97kMr. Edward Moore Kennedy Jr. (Age 63)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 62)R.N., Independent Director Comp: $120kMr. Benjamin Crowninshield Adams (Age 60)Chief Financial Officer Ms. Christine Bent (Age 53)Chief Operations Officer Ms. Cara BabachicosChief Information OfficerMr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMore ExecutivesKey CompetitorsTalkspaceNASDAQ:TALKThe Pennant GroupNASDAQ:PNTGDocGoNASDAQ:DCGOGeneDxNASDAQ:WGSSharecareNASDAQ:SHCRView All CompetitorsInstitutional OwnershipKent Lake Capital LLCBought 285,536 shares on 2/14/2024Ownership: 1.242%Strs OhioSold 3,600 shares on 1/30/2024Ownership: 0.051%View All Institutional Transactions INNV Stock Analysis - Frequently Asked Questions Should I buy or sell InnovAge stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares. View INNV analyst ratings or view top-rated stocks. What is InnovAge's stock price target for 2024? 2 Wall Street analysts have issued 12 month target prices for InnovAge's shares. Their INNV share price targets range from $6.00 to $7.00. On average, they predict the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 66.2% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts. How have INNV shares performed in 2024? InnovAge's stock was trading at $6.00 on January 1st, 2024. Since then, INNV shares have decreased by 34.8% and is now trading at $3.91. View the best growth stocks for 2024 here. When is InnovAge's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our INNV earnings forecast. How can I listen to InnovAge's earnings call? InnovAge will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) released its earnings results on Monday, February, 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.03). The company earned $188.90 million during the quarter, compared to analyst estimates of $181.51 million. InnovAge had a negative trailing twelve-month return on equity of 10.53% and a negative net margin of 4.38%. During the same quarter in the prior year, the company earned ($0.07) EPS. What guidance has InnovAge issued on next quarter's earnings? InnovAge updated its FY 2024 earnings guidance on Tuesday, February, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $725.0 million-$775.0 million, compared to the consensus revenue estimate of $755.9 million. When did InnovAge IPO? InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup acted as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INNV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
